Company facts
- Industry
- Hospital & Medical Service Plans
- Headquarters
- St Louis, Missouri
- Most recent report
- 8-K, filed Oct 27, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1071739
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 31
News 8 of 148
Prospectuses and Registrations 8 of 29
- S-8 Registration statement for an employee plan May 19, 2025
- S-3ASR Automatic shelf registration Feb 21, 2024
- 424B5 Prospectus supplement for an offering Jan 4, 2022
- S-8 Registration statement for an employee plan Jan 4, 2022
- 424B5 Prospectus supplement for an offering Jul 30, 2021
- FWP Free writing prospectus Jul 30, 2021
- 424B5 Prospectus supplement for an offering Jul 29, 2021
- 424B5 Prospectus supplement for an offering Jun 25, 2021
Proxies 8 of 34
- DEFA14A Extra proxy material Mar 26, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 26, 2026
- PX14A6G Shareholder's own proxy material Apr 14, 2025
- PX14A6G Shareholder's own proxy material Apr 11, 2025
- DEFA14A Extra proxy material Mar 27, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2025
- PX14A6G Shareholder's own proxy material Apr 3, 2024
- DEFA14A Extra proxy material Mar 29, 2024
Ownership 8 of 716
- 4 Insider reported a trade Oct 15, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 16, 2026
- 4 Insider reported a trade Aug 27, 2026
Other 8 of 43
What to read: Sep 2026 10-Q
SECSift found 2 of 11 sections worth reading, with 0 positive, 7 notable, and 5 negative flags.
Financial Statements (Item 1)
Financial statements with notes: debt repurchases, receivable sale, segment shifts, and litigation.Notable- Magellan Health assets and liabilities of $312M each classified as held for sale as of Sept 30, 2026.
- Sold $1B of Part D risk-sharing receivables for $970M in March 2026, recording a $30M pre-tax loss.
- No premium deficiency reserve recorded for 2026 Medicare Advantage, vs $282M reserve in Q3 2025.
- Risk adjustment net payable reduced by $541M after CMS final transfer announcement in June 2026.
- Repurchased $1.85B of senior notes in 9M 2026, funded partly by $970M from selling Part D receivables.
- Recorded $297M in severance costs in Q3 2026 from a voluntary separation program; expects $50M-$100M more.
Management's Discussion (Item 2)
MD&A with quantified operating results, segment margins, liquidity, and regulatory risks.Negative- California will transition ~175,000 Medi-Cal UIS members from managed care to fee-for-service starting Jan 2027, cutting revenue.
- Operating cash flow was negative $3.7B in Q3 2026 due to timing of pass-through payments.
- Centene is protesting Medicaid procurement losses in Georgia and Texas; if unsuccessful, future results would be impacted.
- Medicare Advantage star ratings dropped sharply: 42% of members in 3.5+ star plans for 2028 vs 60% for 2027, hitting future revenues.
What changed: Sep 2026 vs. Jun 2026
About 5% of CNC's Sep 2026 10-Q is new information. 16 paragraphs were added, 146 changed, and 15 removed. Below are the most important lines SECSift identified.
Changed
- 2025 risk adjustment pre-tax benefit fell to $480 million from $481 million.
- Basic loss per share improved to $(0.14) from $(13.50) in Q3 2025.
- Cash and cash equivalents fell to $20,700 million from $24,151 million at June 30, 2026.
- Expected net dividends from insurance subs fell to ~$20 million from ~$600 million.
- Long-term debt reduced to $15,454 million from $16,030 million at June 30, 2026.
- Net loss of $71 million in Q3 2026 vs net loss of $6,631 million in Q3 2025, a $6,560 million improvement.
- Total assets decreased to $79,280 million from $83,012 million at June 30, 2026.
- 2026 Medicare Advantage Star Ratings updated to 60% in 3.5+ stars, 20% in 4-star.
- Exhibit 101 now references the quarter ended September 30, 2026, instead of June 30, 2026.
Everything here comes from Centene Corp's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Oct 27, 2026, from the 10-Q for Sep 2026.